Senior insider sale
Chief Financial Officer at LIFECORE BIOMEDICAL, INC. \DE\ — senior position signals high conviction
$387.5K
71.61K shares
What this filing means
MORBERG JOHN D plans to sell 71.61K shares of LIFECORE BIOMEDICAL, INC. \DE\ valued at approximately $387.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/31/2024ACC: 0001957799-24-000293
Officer· Chief Financial Officer
Since Jan 2021
71.61K
Shares to sell
$387.5K
Approx. market value
81.98K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months2
Bonus
N/A
10/6/2024
4KRSUs
N/A
9/26/2024
77.98KTotal acquired81.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/6/2024 | Bonus N/A | 4K | — |
9/26/2024 | RSUs N/A | 77.98K | — |
| Total | 81.98K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
5.19K
Market value
$25.6K
10/17/2024
—Completed
Units to sell
7.43K
Market value
$38.0K
10/7/2024
—Completed
Units to sell
12K
Market value
$60.7K
10/4/2024
—Completed
Units to sell
3K
Market value
$14.7K
10/2/2024
—Completed
Units to sell
3K
Market value
$15.5K
9/20/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
40.99K
Market value
$232.9K
10/31/2024
Total
Units
71.61K
Value
$387.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/17/2024 | 5.19K | $25.6K | — | Completed |
10/7/2024 | 7.43K | $38.0K | — | Completed |
10/4/2024 | 12K | $60.7K | — | Completed |
10/2/2024 | 3K | $14.7K | — | Completed |
9/20/2024 | 3K | $15.5K | — | Completed |
| Planned — Approximate Date | ||||
10/31/2024 | 40.99K | $232.9K | Nasdaq | Planned |
| Total | 71.61K | $387.5K | ||